GEM implantation reduced the protein level of EGFR by promoting its c-CBL-mediated ubiquitination and degradation, thus inhibiting its downstream effects, such as tumor cell growth, angiogenesis, and metastasis (Figure 6). Here, EGFR is linked to neoplasm.